Abbott Laboratories
ABTAbbott Laboratories (ABT) is a Healthcare company that currently yields 2.06% — trading near fair value based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $86.80 and the overvaluation threshold at $134.62. Abbott Laboratories holds a quality score of 60/100 (Good), reflecting 54 consecutive years of dividend growth with a 79% payout ratio. The 5-year dividend CAGR stands at 12.7%.
ABT Dividend Yield History — Weiss Valuation
Distance to undervalued
Waiting for a better entry
Needs about 12.5% downside to reach the Weiss buy zone
Undervaluation starts near $86.80, where the annual dividend would imply roughly 2.35% yield. That is 0.29% above today's yield.
Buy-zone price
$86.80
Target yield
2.35%
Research checklist
What to clear before buying the yield
Updated Oct 1, 2026
Dividend durability
54YLong dividend history supports a deeper look.
Earnings payout
79%Coverage deserves a closer look in filings.
Cash payout
60%Free cash flow coverage supports the payment.
Dividend growth
12.7%Recent growth adds income compounding potential.
What changed
What changed since the last update
2026-09-30 → 2026-10-01
Price
-1.8%$100.95 → $99.17
Price fell 1.8% since the prior snapshot.
Why Now?
Abbott Laboratories is trading at a fair valuation relative to its dividend history.
Current yield 2.1% vs historical max 3.4% (60% of maximum).
10 consecutive years without a dividend cut.
Elevated payout ratio of 79%.
What matters now
Read the signal before the headline yield
Valuation is neutral here: quality has to do more of the work than entry price.
The 60/100 quality score calls for selective follow-up, not autopilot.
Start by checking whether payout coverage and business durability still support the dividend.
ABT Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$232
Year 10 Income
$961
Yield on Cost
10.26%
Total Income
$5,088
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
Track actual vs. projected
See what ABT dividends you actually received with Sharesight
Dividend income log · Yield on cost · DRIP cost basis · Tax reports
More research
Full price history & technical analysis
TradingView ↗Fundamentals, valuation & analyst ratings
FinViz ↗Moat rating & analyst fair value
Morningstar ↗Track dividends received & tax reports
Sharesight ↗ABT Dividend Quality Score
Quality Score
Good
Key Metrics
Invest in ABT
Check Abbott Laboratories availability and current costs on eToro
Check eToro terms and availability →DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.
In-depth analysis
→ ABT Dividend Analysis ArticleRelated Reading
Collections